Louisiana 2018 Regular Session

Louisiana Senate Bill SB507

Introduced
4/2/18  
Introduced
4/2/18  
Refer
4/3/18  
Refer
4/3/18  
Report Pass
4/11/18  
Engrossed
4/17/18  
Refer
4/18/18  
Refer
4/18/18  
Report Pass
4/26/18  
Report Pass
4/26/18  
Enrolled
5/15/18  
Enrolled
5/15/18  
Chaptered
5/25/18  
Chaptered
5/25/18  
Passed
5/25/18  

Caption

Provides relative to Medicaid managed care organizations. (8/1/18)

Impact

The enactment of SB 507 will profoundly influence the operational protocols of Medicaid managed care organizations. By setting clear guidelines for provider notifications and accountability for claims, it attempts to safeguard against fraudulent practices while also securing prompt payments to providers for services rendered. Furthermore, the bill introduces a structural mechanism whereby providers can appeal decisions related to deficiencies, fostering an environment of accountability that could enhance the integrity of service delivery within Louisiana’s Medicaid system.

Summary

Senate Bill 507 introduces substantial regulations pertaining to Medicaid managed care organizations in Louisiana. The bill mandates that these organizations provide written notice to contracted providers regarding their status and obligations, specifically detailing effective dates for contracts and re-credentialing processes. This effort is aimed at ensuring transparency and minimizing disruptions in service delivery for Medicaid recipients, as it outlines specific timelines for providers to respond to notices of deficiencies related to their enrollment status.

Sentiment

The discussions surrounding SB 507 appeared to be largely supportive, with legislators recognizing the importance of maintaining robust oversight over the Medicaid managed care landscape. Supporters argue that the bill will help rectify existing issues regarding provider payments and misinformation from managed care organizations, ultimately improving care for Medicaid recipients. However, there were concerns raised about the potential for bureaucratic delays and the complexity of compliance with the new regulations, suggesting a need for careful implementation to avoid unintended consequences.

Contention

Some points of contention arose regarding the balance of provider accountability and the autonomy of managed care organizations. While proponents hailed the bill as a necessary step towards ensuring that providers meet designated standards, critics feared it could place additional burdens on organizations that may inadvertently lead to decreased participation in Medicaid programs. This emphasizes the ongoing tension between ensuring provider accountability and maintaining a flexible and accessible healthcare system.

Companion Bills

No companion bills found.

Previously Filed As

LA SB351

Provides relative to Medicaid managed care organizations. (8/1/18)

LA SB185

Provides relative to Medicaid and certain managed health care organizations providing health care services to Medicaid beneficiaries. (1/1/14) (RR1 See Note)

LA SB281

Provides relative to contracts with Medicaid managed care organizations. (8/1/20)

LA SB108

Provides relative to mental health rehabilitation services contracts with Medicaid managed care organizations. (1/1/22) (EG NO IMPACT See Note)

LA SB357

Provides relative to Medicaid managed care for individuals receiving long-term services and supports. (8/1/18) (OR +$1,250,000 GF EX See Note)

LA SB130

Provides relative to contracts for Medicaid pharmacy benefit management services. (8/1/18)

LA SB59

Provides relative to prepayment reviews conducted by Medicaid managed care organizations. (8/1/22)

LA HB105

Medicaid; restrict frequency of managed care organizations transferring enrollees to other organizations.

LA HB251

Medicaid; restrict frequency of managed care organizations transferring enrollees to other organizations.

LA HB1058

Medicaid; restrict frequency of managed care organizations transferring enrollees to other organizations.

Similar Bills

NJ A5531

Establishes "Equitable Drug Pricing and Patient Access Act."

NJ S3538

Establishes "Equitable Drug Pricing and Patient Access Act."

NV SB9

Revises provisions relating to Medicaid. (BDR 57-290)

TX HB2453

Relating to the operation and administration of Medicaid, including the Medicaid managed care program.

NJ A2491

Requires all Medicaid managed care organizations to permit all pharmacies in State to dispense prescriptions for all covered medications.

NJ S1076

Requires all Medicaid managed care organization to permit all pharmacies in State to dispense prescriptions for all covered medications.

NJ A2332

Requires all Medicaid managed care organizations to permit all pharmacies in State to dispense prescriptions for all covered medications.

NJ A562

Establishes certain penalties on clinical laboratories regarding receipt of Medicaid overpayments, and on entities engaged in business with such clinical laboratories.